The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I watched this a year ago after a relative died, you tube 1hr 52mins, dr stanislaw burzynski texas usa, the cancer cure,this has been suppressed for 39 years, the fda didnt like his methods as it didnt comply with there needs.......... or the needs of big pharma,,.
Yes,50:50..do u know why??...because sp. remains on the same level 3.70-4p range..understood??
Give yourself a shake and read your post again! You are stating that the volume is perfectly weighted at 50/50… Listen in the next three weeks there could be another round of fundraising to prop up all of these potential contracts/partnerships… funny how they can’t secure any respectable revenues. 🤡
Who told you that daily volume is all sells??
I told you only that volume was over60m..and then u have to divide volume by half and you find out...30m sells vs 30m buys
Anyway-in next 3 weeks we find out which one of us is an idiot..
The only idiot is you my friend...not all of the daily volumes are sells you 🤡.... These BBs should be closed off to people like you, and you invest money.... frightening.
Https://www.londonstockexchange.com/news-article/FAB/follow-on-project-award-and-r-d-update/16319228 ,They are generating money, next RNS on financials will prove that
It looks like you are completely idiot my friend. Just press Fab share chart and count on volume...easy...but not for the idiots
Sorry forgot to add, STRONG SELL IMHO DTOR GLA...
Absolute nonsense, there wasnt more than 4 or 5 trades a day for over 6 weeks... theres between 25-30M sat in the background and you know it. As soon as there is any news theres a frenzy of selling. No one is buying is for that reason, why buy shares that are going to drop on news... DYOR
Well not all business is good business, this could be the issue maybe?
If you are taking on development work which will ultimately benefit this "leading global provider" why are they doing it for a token fee? it totally devalues the skills and services of their team. Time and resource that could go into a paying client.
I think that a lot of these small bios are so into the sciences that they just lack any kind of commercial acumen, they will do everything for free as long as shareholders will keep adding the cash to maintain them. This is not a direct criticism of FAB its all over the sector frankly.
10's m??? placing shares???...Dr.M...did you notice since placing day was 60m shares traded???..IMHO...there is no more then 5-6 m left....
They’re not taking contracts with zero revenue - they clearly stated they will receive fees for their services on that RNS yesterday, just that they’re not material. This has been clear from start that Optiphage is a lower price point service - they’ve been clever here in that they’ve managed to secure long stream revenue potential from a more attractive lower price service as part of diversification, which is evidently working.
NO revenue, 10s of millions of PLACING shares still in the background, BoDs paid in shares, projects DELAYED, stringent cost cutting across all of the company, taking contracts with ZERO revenue.... Theres been next to no revenue since they fund raised at an enormous 84% DISCOUNT May 2023.. Hardly looking like an investment thats about to turnaround, IMHO DYOR GLA...
Well done great price
Topped up,
Yeah I took some more today, they are turning things around and getting on with growing the company. Today’s deal will generate regular income and open pathways to lots.
More news also coming
I’m very pleased that we’re moving into all possible areas to generate future revenues ,
I also love the move into the veterinary sector and potential huge revenue returns in the near term.
Very interesting proactive one to one with investors presentation.
To be fair they’re doing exactly what they intended to do this year and more.
Great listen.
https://www.google.com/search?q=proactive+investor+fusion+antibodies+plc&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari#fpstate=ive&vld=cid:14b5e405,vid:IAvbf90GgvQ,st:0
Its like i said, all JAM... thats why the SP has been decimated..
NO REVENUE..... -34.59 (-89.84%)past year..... True facts.... Ciao
Turnaround just begun,
Revenue follows on shortly afterwards.
Its 4p not 40p , mkcap less than 4m
I’ll be reminding you in the coming weeks months,
I’m interested in your views.
NO REVENUE..... -34.59 (-89.84%)past year..... True facts and no Jam....
Credit
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces the receipt of an R&D tax credit from HMRC in respect of the financial year ended 31 March 2023, relating to work performed on the development and optimization of the OptiMAL® platform, as well as other R&D projects in bioinformatics, antigen design and cell culture. The value of the tax credit is in line with expectations at almost £280k, which reflects the Company's continued investment in R&D projects that maintain Fusion at the forefront of technology in the antibody market. The technologies have been well received by partners and potential partners with the OptiMAL® platform notably undergoing validation through an agreement with the National Cancer Institute in the USA. Fusion will maximise the impact of the tax credit with the generation of revenue streams from the R&D projects that were supported.
Adrian Kinkaid, CEO of Fusion, said: "The R&D tax credit system is of enormous benefit to companies developing cutting edge technologies such as we continue to do at Fusion. We are now beginning to reap the benefits of the resultant technology platforms with an elevated profile in our field and anticipate considerable commercial growth to be generated from them in the coming years."
NO revenue, 10s of millions of PLACING shares, BoDs paid in shares, projects DELAYED, stringent cost cutting across all of the company, contracts with ZERO revenue.... Theres been next to no revenue since they fund raised at an enormous 84% DISCOUNT May 2023... You think that shouts out strong buy...🤣🤡🤣🤡🤣🤡
Just the beginning of the turnaround and already this year we’ve seen two contracts and a collaboration , partnership with the NCI, National Cancer institute in the US.
Some going in Less than three months.
This year is going to be transformational for the company and for us shareholders .
Revenue will follow not far behind.
Strong buy 100 percent.
Where did you see that enable significant cash flow from royalty’s line Chris?
Not baffling at all. There is no revenue and 10s of millions of placing shares in the background and there has been for a few months. Any news will be heavily sold into, the slightest rise and wallop sellers. This needs contracts with revenue to get rid of the overhang until then under 4p, deal with it peeps... Strong Sell....